How much does it cost to develop a new drug?

Various malaria experts

Last month MMV co-hosted a meeting for donors in Barcelona on the importance of partnerships in the fight against malaria, and took this opportunity to interview experts in this field on the need for sustainable financing.

Dr Robert Newman


Global Malaria Programme (GMP), World Health Organization

Dr Dennis Schmatz

President and CEO

Medicines for Malaria Venture; President, MMV North America, Inc. Board; Former Vice President, Head of Tsukuba Research Institute, Merck Research Laboratories

Dr Carlos Morel


Center for Technological Development in Health, Oswaldo Cruz Foundation (FIOCRUZ); MMV Board Member